TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Curcumin, Doxorubicin
Phytochemical Name Curcumin (PubChem CID: 969516 )
Anticancer drug Name Doxorubicin (PubChem CID: 31703 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 823
Pair Name Curcumin, Doxorubicin
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Inhibition-->Angiogenesis
Gene Regulation Up-regulation Expression CASP3 hsa836
Down-regulation Expression CDH1 hsa999
Up-regulation Expression VIM hsa7431
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
H22 Hepatocellular carcinoma Mus musculus (Mouse) CVCL_H613
In Vivo Model BALB/c mice were subcutaneously implanted with H22 cells at a concentration of 1×10⁶ cells per mouse.Therapeutic drugs (DOX, 3 mg/kg; CUR, 0.75 mg/kg) were injected into the mice in the treated groups (saline, DC, DOX/Pep2, DOX/Pep1, DC/Pep2, DC/Pep1) via the tail vein every other day for 14 days starting on day 6. The tumor sizes and mouse body weights were measured every other day.
Result Our findings provide a novel and simple approach to nhibit the growth and metastasis of hepatocellular carcinoma.
03. Reference
No. Title Href
1 Morphologically transformable peptide nanocarriers coloaded with doxorubicin and curcumin inhibit the growth and metastasis of hepatocellular carcinoma. Mater Today Bio. 2023 Dec 12;24:100903. doi: 10.1016/j.mtbio.2023.100903. Click
It has been 46842 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP